Callan Family Office LLC Purchases 613 Shares of Mettler-Toledo International, Inc. $MTD

Key Points

• Callan Family Office LLC increased its stake in Mettler-Toledo International by 306.5%, owning a total of 813 shares worth approximately $955,000 after purchasing 613 additional shares in the second quarter.
• Analysts have raised price targets for Mettler-Toledo International, with Citigroup increasing its target from $1,400 to $1,600 and Evercore ISI setting it at $1,400, indicating strong investor sentiment.
• Mettler-Toledo International reported quarterly earnings of $10.09 per share, beating estimates by $0.51, and achieved revenue of $983.22 million, which is a 3.9% increase from the prior year.

Callan Family Office LLC grew its position in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 306.5% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 813 shares of the medical instruments supplier's stock after purchasing an additional 613 shares during the quarter. Callan Family Office LLC's holdings in Mettler-Toledo International were worth $955,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Greenleaf Trust boosted its stake in Mettler-Toledo International by 1.2% during the first quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier's stock worth $1,030,000 after buying an additional 10 shares in the last quarter. Brooklyn Investment Group boosted its stake in Mettler-Toledo International by 12.8% during the first quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier's stock worth $104,000 after buying an additional 10 shares in the last quarter. Sax Wealth Advisors LLC boosted its stake in Mettler-Toledo International by 2.8% during the second quarter. Sax Wealth Advisors LLC now owns 372 shares of the medical instruments supplier's stock worth $437,000 after buying an additional 10 shares in the last quarter. Sequoia Financial Advisors LLC boosted its stake in Mettler-Toledo International by 1.8% during the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock worth $740,000 after buying an additional 11 shares in the last quarter. Finally, Albion Financial Group UT lifted its holdings in shares of Mettler-Toledo International by 1.5% during the first quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock valued at $890,000 after acquiring an additional 11 shares during the period. Institutional investors own 95.07% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on MTD shares. Weiss Ratings reissued a "hold (c)" rating on shares of Mettler-Toledo International in a report on Wednesday, October 8th. Evercore ISI lifted their price objective on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an "outperform" rating in a report on Tuesday, October 7th. Citigroup lifted their price objective on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a report on Thursday, August 21st. Barclays lifted their price objective on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an "overweight" rating in a report on Thursday, October 2nd. Finally, Robert W. Baird lifted their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a report on Monday, August 4th. Five investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, Mettler-Toledo International presently has an average rating of "Hold" and a consensus target price of $1,336.50.

Insider Activity at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total value of $376,227.00. Following the completion of the transaction, the chief financial officer directly owned 5,095 shares of the company's stock, valued at $6,389,588.55. The trade was a 5.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Gerry Keller sold 165 shares of the business's stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the sale, the insider directly owned 94 shares of the company's stock, valued at $123,012.16. This represents a 63.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,827 shares of company stock valued at $2,371,208 over the last ninety days. 0.77% of the stock is owned by insiders.

Mettler-Toledo International Stock Down 2.5%

Mettler-Toledo International stock opened at $1,274.39 on Monday. The stock has a 50-day simple moving average of $1,278.97 and a 200 day simple moving average of $1,190.01. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,486.76. The stock has a market capitalization of $26.25 billion, a price-to-earnings ratio of 32.27, a P/E/G ratio of 3.82 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business had revenue of $983.22 million during the quarter, compared to analysts' expectations of $957.41 million. During the same period in the previous year, the business posted $9.65 earnings per share. The firm's revenue for the quarter was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.